Lincoln Pharmaceuticals Peer Comparison

Lincoln Pharmaceuticals Ltd. stands out among its peers with strong revenue growth, robust profitability metrics, and low debt levels, indicating a solid performance in the Pharmaceuticals & Drugs sector. Its valuation ratios also suggest it is attractively priced compared to its peers, making it a compelling pick for investors looking for growth and value.

• • Lincoln Pharmaceuticals has the highest revenue growth (YoY) at 13.76%.
• • It boasts the lowest debt-to-equity ratio at 0.0018, indicating strong financial stability.
• • The company has an attractive PEG ratio of 0.32, suggesting good growth potential relative to its price.

• • Lincoln Pharmaceuticals Ltd.: Strong revenue growth and low debt levels make it a leader in the sector.
• • Dr. Reddy's Laboratories Ltd.: High profitability with solid ROE and low valuation metrics make it a good pick.
• • Mankind Pharma Ltd.: Outstanding revenue growth of 155.25% over three years, indicating strong market demand.